Introduction
Bile acids are steroid derivatives that are produced by the hepatocytes of the liver and excreted in bile. These molecules play an important role in micelle formation for lipid digestion and uptake of fat-soluble vitamins in the intestines [1] . The majority of bile acids (95%) is then reabsorbed and transported back to the liver by the portal circulation.
Bile acid homeostasis in the liver is maintained by specific bile acid transporters on the hepatocytes. Uptake at the basolateral side relies predominantly on the Na + -dependent Taurocholate Cotransporting Polypeptide (NTCP) and also the Organic Anion Transporting Polypeptides (OATPs). Once in the hepatocyte, excretion in the bile canaliculi is mainly mediated by the Bile Salt Export Pump (BSEP) [2] .
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However, this highly efficient hepatobiliary transport of bile acids can be disturbed by xenobiotics that inhibit the aforementioned bile acid transporters or in certain liver diseases such as primary biliary cirrhosis or progressive familial intrahepatic cholestasis (PFIC) [3] [4] [5] . A toxic buildup of bile acids in the hepatocytes, termed cholestasis, can then present itself. Clinical features may consist of nausea, abdominal pain, jaundice and pruritus [6] . An accurate in vivo determination of bile acid transport efficiency can therefore be valuable for detection or evaluation of liver disease in both drug development and clinic.
To visualize physiological processes on a molecular level in vivo, Positron Emission Tomography (PET) is the imaging modality of choice. The possibility for close resemblance of the PET-radiotracer and the endogenous substrate under investigation gives this imaging technique an important asset [7] . Recently, a number of studies with 11 C or 18 F labeled bile acid PET-tracers have been published. Frisch et al. evaluated 11 C labeled bile acids, conjugated with sarcosine or N-methyl taurine in pigs [8, 9] . These tracers were able to visualize hepatobiliary transport and can provide valuable information in hepatobiliary diseases, although the short half-life of the 11 C isotope limits their use. Several 18 F labeled bile acids were developed to overcome this issue. Jia et al. developed a 18 F labeled bile acid for studying Farnesoid X Receptor-(FXR-) related diseases, using a click reaction of 1,3-dipolar cycloaddition of terminal alkynes and organic azides [10] . However, this modification removes the terminal carboxylic acid moiety that is critical for recognition by the bile acid transporters [11] . Testa et al. improved this click chemistry approach by retaining the carboxylic acid functional group [12] . Nevertheless, for both 18 F labeled compounds the introduction of a long 1,2,3-triazole linked fluoroalkyl sidechain on the carboxylic acid terminus encompasses a substantial addition to the steroid structure. This might result in altered hepatobiliary transport, compared to endogenous bile acids.
Because of the need for a 18 F labeled bile acid with only a minimal modification in molecular structure compared to an endogenous bile acid, 3 -[
18 F]fluorocholic acid (3 -
was developed by our research group [13] . The bile acid structure for 3 -[ 18 F]FCA is cholic acid, of which the 3 alpha OH group was substituted for a 3-beta fluorine. This tracer showed transport by NTCP, OATP, and BSEP in vitro and could visualize hepatobiliary transport in vivo and druginduced alterations thereof.
Given the increased interest in bile acid PET-imaging, a further understanding of the impact of fluorine-OH substitution on bile acid handling in vitro and in vivo can be beneficial. Therefore, in this study a number of fluorinated analogues of cholic, chenodeoxycholic, and glycocholic acid were synthesized, evaluated, and compared in vitro and in vivo in mice. 18 F-Labeled Bile Acids. The 18 Fisotope was introduced on the bile acid skeleton by a nucleophilic substitution on a suitable mesylate, protected precursor molecule of which the synthesis can be found in Supplementary Data (available ). The conceived 18 F labeled bile acids are shown in Figure 1 . The radiosynthesis was performed as described earlier [13] . In short, [ 18 F]fluoride (1.3 GBq) was trapped on a Sep-Pak QMA-column (Waters, Zellik, Belgium) that was preconditioned with 5 mL 0.01 M K 2 CO 3 and 5 mL ultrapure water. The activity was eluted in a radiosynthesis vial with 1 mL 9 : ∘ C. Afterwards, the vial was cooled and 100 L 5 M NaOH was added. The mixture was shaken and heated again at 120 ∘ C for 10 minutes. After cooling and neutralization of the basic reaction mixture, purification was performed by a semipreparative HPLC-system (Grace Econosphere C18 10.0 × 250 mm, 10 m; 6 mL/min 10% AcN in H 2 O -> 100% AcN in 20 minutes; radiodetection (Ludlum Measurements Inc.)). The desired HPLC-fraction was collected, diluted with ultrapure water to 50 mL, and loaded on a Sep-Pak C18 Plus short cartridge (preconditioned with 10 mL EtOH and 10 mL ultrapure water). After washing with 10 mL ultrapure water, the 18 F-labeled bile acid was eluted off the column with 1 mL EtOH in a separate vial. This fraction was evaporated under a gentle N 2 -flow and heating. Finally, 500 L phosphate buffered saline was added to reformulate the tracer for in vivo use.
Materials and Methods

Radiosynthesis of the
The logD-value, stability (in formulation for use and mouse serum), and identity of the tracer were assessed as described earlier [13] . Radiochemical purity and percentage 18 F-labeling of precursor were determined by radio-TLC (silica gel TLC; with 10% MeOH in CH 2 Cl 2 and 4 : 1 AcN : H 2 O, resp.). , respectively (Solvo Biotechnologies), were used. Maintenance of these cell cultures was described earlier [13] . Ki-values of the different bile acids were calculated using the experimentally determined IC50-and Km-parameters in the Cheng-Prusoff equation (GraphPad Prism v3.00 Software) (see (1) 
In Vitro
where refers to inhibition constant; IC50 refers to concentration of fluorinated bile acid that causes a 50% decrease in 3 H labeled substrate uptake; [ ] refers to concentration of 3 H labeled substrate; Km refers to Michaelis-Menten constant of 3 H labeled substrate Cells were seeded in 24-well plates at 400,000 cells/well. The culture medium was aspirated after 24 hours and the cells were washed twice with 1 mL 10 mM HEPES-Hank's Balanced Salt Solution (HBSS; with Ca and Mg; 37 (NTCP) or [ 3 H]EbG (OATP1B1) for 15 minutes at 37 ∘ C. All dosing solutions were formulated in the washing buffer and dosing was executed in triplicate. The incubation was stopped by placing the plates on ice and adding 1 mL ice-cold 1% BSA HBSS-solution. The supernatant was aspirated and the cells were washed twice with 2 mL ice-cold HBSS-solution. NaOH (250 l, 0.1 M) was added to lyse the cells and the plates were shaken (15 minutes, 37 ∘ C). Aliquots of this lysate were subjected to liquid scintillation counting (TriCarb 2900 TR; Perkin Elmer) and protein determination with a BCA-assay (ThermoFisher Scientific).
In Vitro Efflux Assays. Transport of the bile acids by BSEP was evaluated by their inhibition of [
3 H]TC uptake in BSEP membrane vesicles (Pharmtox). Cholic acid (CA) was added to the test compound panel as a reference. Ki-values of the different bile acids were calculated using the experimentally determined IC50-and Km-parameters in the Cheng-Prusoff equation (GraphPad Prism v3.00 Software) (see (1) ). The assay was performed in V-tip 96-well plates; each well contained 3.75 g membrane vesicle, 10 mM MgCl 2 , 10 mM Tris, 4 mM adenosine triphosphate (ATP), and 250 mM sucrose. A concentration range of 0-50 M [
3 H]TC was included for the Km-determination. To determine the IC50s, 0-2500 M of bile acid was used with 0.65 M [
3 H]TC. All dosing was performed in triplicate. The plates were suspended in a 37 ∘ C water bath 1 minute before the incubation. Incubation was started by adding 10 L of the ATP solution or buffer solution (negative control). Each well contained a final volume of 30 L and the plates were incubated for 10 minutes at 37 ∘ C. Transport was stopped by placing the plates on ice and adding 150 L ice-cold buffer solution. The contents of each well were pipetted in a glass fiber filter plate (Multiscreen HTS plates; Merck Millipore) and washed 3 times with 200 L ice-cold buffer solution. Finally, 100 L 0.1 M NaOH was added: lysis of the vesicles took place for 10 minutes at room temperature. An aliquot was used for liquid scintillation counting. Food and water were provided ad libitum, but the animals were fasted overnight before a PET/CT-scan. They were anesthetized with 1.5 v : v% isoflurane in O 2 and placed on a heated bed. To allow injection of the tracer, a polyethylene intravenous line was inserted in the lateral tail vein and fixed. After the animals were transferred to the scanner animal bed, a 1 hour PET-scan was started and 9 MBq tracer was injected directly after starting the scan. Following this PETscan, 9 MBq [
18 F]FDG was injected and twenty minutes later, a second PET-scan with a 20-minute acquisition time was started.
All PET-scans were obtained in list-mode and were iteratively reconstructed (50 iterations). The 1-hour scan was reconstructed in the following frames: 8 × 15 s; 16 × 30 s; 10 × 60 s; 20 × 120 s. For presentation purposes, Maximum Intensity Projection PET/CT images were generated in Amide software. The data were analyzed using Pmod software v3.405 (PMOD Technologies): Regions Of Interest (ROIs) were drawn manually over the liver, gallbladder, and intestines. On the static [
18 F]FDG scan, the left ventricle was delineated and this ROI was pasted on the dynamic scan to obtain an image-derived arterial blood concentration. The uptake of radioactivity in liver, gallbladder, and intestines was expressed as a percentage of the injected dose (% ID) and normalized for the weight of a 20 g mouse. The % ID in these organs was monitored in function of time to obtain timeactivity curves (TACs). Biliary clearance of the tracers was determined with equation 2 from Ghibellini et al. [14] Biliary clearance = cumulative amount of tracer in gallbladder&intestines AUC blood concentration 0→60 min .
The Area Under the Curve (AUC), % ID, and time- 
Results
Radiosynthesis of the 18 F-Labeled Bile Acids. Differences in radiolabeling yield of the precursors for radiosynthesis with [
18 F]fluoride were observed ( (Figure 3 and Table 2 ). in the BSEP membrane vesicles. A sigmoidal dose-response curve was fitted on the acquired data points to determine the IC50 and calculate the Ki-value ( Figure 3 and Table 2 ). 18 F]FCA (0.46 ± 0.08 mL/min). No radioactivity was observed in other organs for all tracers under investigation. Time-activity curves of the 18 F labeled bile acids were generated and the relevant parameters were extracted from these graphs (Figure 4 and Figure 5 .
In Vitro Efflux
In Vivo Evaluation of the
Discussion
Cholestasis, a toxic accumulation of bile acids in the liver or blood, may occur in certain liver diseases or can be triggered as a result of a xenobiotic interfering with the hepatobiliary transport of bile acids [15] . It is therefore important to have an adequate tool to evaluate the efficiency of bile acid transport in vivo for clinical use or in drug development.
To that end, PET-imaging of hepatobiliary transport with radiolabeled bile acids is gaining importance. A number of studies have been published in which bile acids were labeled with either 11 C or 18 F on different bile acid structures [8] [9] [10] 12] . Our research group developed 3 -[ 18 F]FCA and the increased interest in hepatobiliary imaging with PET, a further exploration of fluorinated bile acid transport characteristics was performed in this study. A number of fluorinated analogues were conceived: cholic acid derivatives of which the 3, 7, and 12 OH functions were replaced with a fluorine atom, a 3 -fluorine labeled chenodeoxycholic acid, and 3 -fluorine labeled glycocholic acid. These compounds were evaluated on their radiosynthesis characteristics, in vitro and in vivo hepatobiliary transport in wild-type mice.
Of Table 2 . All data are mean ± SD ( = 3).
(approx. 30%) [13] . Labeling of the 3 -[
18 F]FGCA precursor was only 11.51±2.55%. This reduced yield could be attributed to the presence of a more polar amide group on the precursor, which can reduce the [
18 F]fluoride nucleophilic substitution efficiency. LogD values of the three tracers mentioned above were determined and were in line with literature LogD values of cholic acid, chenodeoxycholic acid, and glycocholic acid [16] .
The and gallbladder and intestines (GBI; green curve) of wild-type mice. Uptake of the tracers was expressed as % injected dose (% ID) and normalized for a 20 g mouse. Data are mean ± SD ( = 3 per group). present near the 12 -mesyl-group. In vitro data for 12 -FCA could be acquired, but no in vivo PET-imaging was possible.
Ki-values of CA, 3 FCA, 3 FGCA, 3 FCDCA, and 12 FCA for the bile acid transporters NTCP, OATP1B1, and BSEP were determined as an affinity measure. It was demonstrated that these compounds caused a concentration dependent decrease in uptake of the tritium labeled model substrates of NTCP, OATP1B1, and BSEP. The substitution of the 3-OH function by a more lipophilic fluorine atom on the 3 -and 3 -position of CA causes an increase in affinity for NTCP and OATP1B1, yet gives rise to a decrease in affinity for the BSEP-transporter compared to CA. Although both 3-FCA epimers are a substrate for the bile acid transporters, 3 -FCA displays a slightly higher affinity than 3 -FCA for NTCP and OATP1B1 (2.53 ± 0.76 M and 5.22 ± 0.56 M, resp., versus 6.18 ± 0.59 and 9.67 ± 0.83 M, resp.). The affinity for BSEP does not change. This difference in affinity for 3 / cholic acid epimers of bile acid transporters was already uncovered in cell lines that express the Apical Sodium-dependent Bile acid Transporter (ASBT; responsible for basolateral uptake of bile acids in the enterocytes). It was found that 3 -OH-bile acids have a lower affinity than 3 OH-bile acids for ASBT [17] . In the present study, the hepatic basolateral uptake transporters NTCP and OATP1B1 also reveal a slight preference in affinity for the 3 -fluorocholic acid epimer. Compound 3 -FGCA, 3 -cholic acid conjugated with the amino acid glycine, showed an increase in affinity for all bile acid transporters under investigation. This is in line with literature data: conjugated bile acids have a higher affinity for NTCP, OATP, and BSEP than nonconjugated bile acids [2, 18] .
The 
